Next Article in Journal
Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
Previous Article in Journal
Low Adenovirus Vaccine Doses Administered to Skin Using Microneedle Patches Induce Better Functional Antibody Immunogenicity as Compared to Systemic Injection
Article

Factors Associated with COVID-19 Vaccine Hesitancy

1
Comprehensive Health Research Center, Universidade NOVA de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal
2
NOVA National School of Public Health, Public Health Research Center, Universidade NOVA de Lisboa, Av. Padre Cruz, 1600-560 Lisboa, Portugal
*
Author to whom correspondence should be addressed.
Academic Editor: Silvio Tafuri
Vaccines 2021, 9(3), 300; https://doi.org/10.3390/vaccines9030300
Received: 4 February 2021 / Revised: 16 March 2021 / Accepted: 18 March 2021 / Published: 22 March 2021
(This article belongs to the Section COVID-19 Vaccines and Vaccination)
It is critical to develop tailored strategies to increase acceptability of the COVID-19 vaccine and decrease hesitancy. Hence, this study aims to assess and identify factors associated with COVID-19 vaccine hesitancy in Portugal. We used data from a community-based survey, “COVID-19 Barometer: Social Opinion”, which includes data regarding intention to take COVID-19 vaccines, health status, and risk perception in Portugal from September 2020 to January 2021. We used multinomial regression to identify factors associated with intention to delay or refuse to take COVID-19 vaccines. COVID-19 vaccine hesitancy in Portugal was high: 56% would wait and 9% refuse. Several factors were associated with both refusal and delay: being younger, loss of income during the pandemic, no intention of taking the flu vaccine, low confidence in the COVID-19 vaccine and the health service response during the pandemic, worse perception of government measures, perception of the information provided as inconsistent and contradictory, and answering the questionnaire before the release of information regarding the safety and efficacy of COVID-19 vaccines. It is crucial to build confidence in the COVID-19 vaccine as its perceived safety and efficacy were strongly associated with intention to take the vaccine. Governments and health authorities should improve communication and increase trust. View Full-Text
Keywords: COVID-19; vaccination; vaccine hesitancy COVID-19; vaccination; vaccine hesitancy
Show Figures

Figure 1

MDPI and ACS Style

Soares, P.; Rocha, J.V.; Moniz, M.; Gama, A.; Laires, P.A.; Pedro, A.R.; Dias, S.; Leite, A.; Nunes, C. Factors Associated with COVID-19 Vaccine Hesitancy. Vaccines 2021, 9, 300. https://doi.org/10.3390/vaccines9030300

AMA Style

Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, Dias S, Leite A, Nunes C. Factors Associated with COVID-19 Vaccine Hesitancy. Vaccines. 2021; 9(3):300. https://doi.org/10.3390/vaccines9030300

Chicago/Turabian Style

Soares, Patricia, João V. Rocha, Marta Moniz, Ana Gama, Pedro A. Laires, Ana R. Pedro, Sónia Dias, Andreia Leite, and Carla Nunes. 2021. "Factors Associated with COVID-19 Vaccine Hesitancy" Vaccines 9, no. 3: 300. https://doi.org/10.3390/vaccines9030300

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop